Biotech News
Valneva SE Signs $32.8 Million Deal to Supply IXIARO to U.S. Military
Valneva SE, a specialty vaccine company, has secured a new one-year contract worth $32.8 million with the U.S. Department of Defense (DoD). Under this agreement, the DoD will purchase IXIARO, a vaccine for Japanese encephalitis (JE), with the possibility of
31 January 2025